| Human CAR T cells with cell-intrinsic PD-1 checkpoint blockade resist tumor-mediated inhibition L Cherkassky, A Morello, J Villena-Vargas, Y Feng, DS Dimitrov, ... The Journal of clinical investigation 126 (8), 3130-3144, 2016 | 956 | 2016 |
| Regional delivery of mesothelin-targeted CAR T cell therapy generates potent and long-lasting CD4-dependent tumor immunity PS Adusumilli, L Cherkassky, J Villena-Vargas, C Colovos, E Servais, ... Science translational medicine 6 (261), 261ra151-261ra151, 2014 | 562 | 2014 |
| Tumor spread through air spaces is an important pattern of invasion and impacts the frequency and location of recurrences after limited resection for small stage I lung … K Kadota, J Nitadori, CS Sima, H Ujiie, NP Rizk, DR Jones, PS Adusumilli, ... Journal of Thoracic Oncology 10 (5), 806-814, 2015 | 505 | 2015 |
| Mesothelin-targeted CARs: driving T cells to solid tumors A Morello, M Sadelain, PS Adusumilli Cancer discovery 6 (2), 133-146, 2016 | 430 | 2016 |
| Mesothelioma: Scientific clues for prevention, diagnosis, and therapy M Carbone, PS Adusumilli, HR Alexander Jr, P Baas, F Bardelli, A Bononi, ... CA: a cancer journal for clinicians 69 (5), 402-429, 2019 | 413 | 2019 |
| Combination immunotherapy with CAR T cells and checkpoint blockade for the treatment of solid tumors R Grosser, L Cherkassky, N Chintala, PS Adusumilli Cancer cell 36 (5), 471-482, 2019 | 366 | 2019 |
| Loss of BAP1 function leads to EZH2-dependent transformation LM LaFave, W Béguelin, R Koche, M Teater, B Spitzer, A Chramiec, ... Nature medicine 21 (11), 1344-1349, 2015 | 364 | 2015 |
| Scientific advances in lung cancer 2015 AS Tsao, GV Scagliotti, PA Bunn Jr, DP Carbone, GW Warren, C Bai, ... Journal of Thoracic Oncology 11 (5), 613-638, 2016 | 341 | 2016 |
| Long-term survival based on the surgical approach to lobectomy for clinical stage I nonsmall cell lung cancer: comparison of robotic, video-assisted thoracic surgery, and … HX Yang, KM Woo, CS Sima, MS Bains, PS Adusumilli, J Huang, ... Annals of surgery 265 (2), 431-437, 2017 | 330 | 2017 |
| Cisplatin-induced antitumor immunomodulation: a review of preclinical and clinical evidence AR de Biasi, J Villena-Vargas, PS Adusumilli Clinical Cancer Research 20 (21), 5384-5391, 2014 | 314 | 2014 |
| A phase I trial of regional mesothelin-targeted CAR T-cell therapy in patients with malignant pleural disease, in combination with the anti–PD-1 agent pembrolizumab PS Adusumilli, MG Zauderer, I Rivière, SB Solomon, VW Rusch, ... Cancer discovery 11 (11), 2748-2763, 2021 | 306 | 2021 |
| Impact of micropapillary histologic subtype in selecting limited resection vs lobectomy for lung adenocarcinoma of 2cm or smaller J Nitadori, AJ Bograd, K Kadota, CS Sima, NP Rizk, EA Morales, ... Journal of the National Cancer Institute 105 (16), 1212-1220, 2013 | 297 | 2013 |
| IASLC multidisciplinary recommendations for pathologic assessment of lung cancer resection specimens after neoadjuvant therapy WD Travis, S Dacic, I Wistuba, L Sholl, P Adusumilli, L Bubendorf, P Bunn, ... Journal of Thoracic Oncology 15 (5), 709-740, 2020 | 285 | 2020 |
| Pretreatment neutrophil-to-lymphocyte ratio and mutational burden as biomarkers of tumor response to immune checkpoint inhibitors C Valero, M Lee, D Hoen, K Weiss, DW Kelly, PS Adusumilli, PK Paik, ... Nature communications 12 (1), 729, 2021 | 265 | 2021 |
| Initial results of pulmonary resection after neoadjuvant nivolumab in patients with resectable non–small cell lung cancer MJ Bott, SC Yang, BJ Park, PS Adusumilli, VW Rusch, JM Isbell, ... The Journal of thoracic and cardiovascular surgery 158 (1), 269-276, 2019 | 258 | 2019 |
| Prognostic significance of adenocarcinoma in situ, minimally invasive adenocarcinoma, and nonmucinous lepidic predominant invasive adenocarcinoma of the lung in patients with … K Kadota, J Villena-Vargas, A Yoshizawa, N Motoi, CS Sima, GJ Riely, ... The American journal of surgical pathology 38 (4), 448-460, 2014 | 246 | 2014 |
| Mesothelin overexpression promotes mesothelioma cell invasion and MMP-9 secretion in an orthotopic mouse model and in epithelioid pleural mesothelioma patients EL Servais, C Colovos, L Rodriguez, AJ Bograd, J Nitadori, C Sima, ... Clinical Cancer Research 18 (9), 2478-2489, 2012 | 221 | 2012 |
| Solid predominant histologic subtype in resected stage I lung adenocarcinoma is an independent predictor of early, extrathoracic, multisite recurrence and of poor … H Ujiie, K Kadota, JE Chaft, D Buitrago, CS Sima, MC Lee, J Huang, ... Journal of clinical oncology 33 (26), 2877-2884, 2015 | 212 | 2015 |
| Clinical impact of immune microenvironment in stage I lung adenocarcinoma: tumor interleukin-12 receptor β2 (IL-12Rβ2), IL-7R, and stromal FoxP3/CD3 ratio are independent … K Suzuki, K Kadota, CS Sima, J Nitadori, VW Rusch, WD Travis, ... Journal of clinical oncology 31 (4), 490-498, 2013 | 208 | 2013 |
| Prognostic immune markers in non–small cell lung cancer K Suzuki, SS Kachala, K Kadota, R Shen, Q Mo, DG Beer, VW Rusch, ... Clinical Cancer Research 17 (16), 5247-5256, 2011 | 193 | 2011 |
